Steward Partners Investment Advisory, LLC P Lx Pharma Inc. Transaction History

Steward Partners Investment Advisory, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.3 $120 - $300	-1,000 Reduced 2.23%	43,875 $5,000
Q4 2022 Feb 15, 2023	SELL	$0.15 - $0.63 $2,322 - $9,752	-15,480 Reduced 25.65%	44,875 $7,000
Q3 2022 Nov 10, 2022	SELL	$0.52 - $3.08 $2,600 - $15,400	-5,000 Reduced 7.65%	60,355 $39,000
Q2 2022 Aug 04, 2022	SELL	$1.9 - $4.18 $9,106 - $20,034	-4,793 Reduced 6.83%	65,355 $159,000
Q1 2022 May 02, 2022	BUY	$3.54 - $8.3 $37,878 - $88,810	10,700 Added 18.0%	70,148 $283,000

Q4 2021 Feb 08, 2022	BUY	$7.69 - $19.66 $140,727 - $359,778	18,300 Added 44.47%	59,448 $476,000
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $373,382 - $650,210	30,555 Added 288.45%	41,148 $794,000
Q2 2021 Aug 13, 2021	BUY	$9.0 - $15.94 $13,500 - $23,910	1,500 Added 16.5%	10,593 $146,000
Q1 2021 May 14, 2021	BUY	$5.24 - $10.14 $47,647 - $92,203	9,093 New	9,093 $82,000
Q3 2018 Oct 23, 2018	SELL	$3.18 - $5.15 $238 - $386	-75 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$3.3 - $4.5 $247 - $337	75 New	75 $0

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.